American Funds Income Fd of Amer F-2 (AMEFX)

Nasdaq • Currently up 0.10 (+0.37%) in today's trading session

3 members of Congress have disclosed 14 trades in American Funds Income Fd of Amer F-2 (AMEFX) via STOCK Act filings. The most recent disclosure was filed by Sheldon Whitehouse on 30 December 2025. The most active traders have been Sheldon Whitehouse (9), Raul Ruiz (3), and John R. Curtis (2). Aggregate disclosed activity totals roughly $48.5K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

American Funds Income Fd of Amer F-2 is currently trading at $27.18, positioned at 49% of its 52-week range ($25.80 – $28.59).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$27.18
24h Change
+0.10 (+0.37%)
52 Week Range
$25.80–$28.59
View on NASDAQ

American Funds Income Fd of Amer F-2 Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for AMEFX

Select to highlight on chart
5 transactions
Compliance: 0%
Sheldon Whitehouse30 Dec 202510 Aug 2026Stock$1,001 - $15,000+3.82%
John R. Curtis4 Nov 202514 Jul 2026Stock$1,001 - $15,000-0.15%
John R. Curtis4 Nov 202514 Jul 2026Stock$15,001 - $50,000-0.15%
Raul Ruiz1 Oct 202513 May 2026PurchaseStock$1,001 - $15,000N/A
Sheldon Whitehouse29 Jul 202510 Aug 2026Stock$15,001 - $50,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

No overview data available for this stock

No earnings data available for this stock.

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

XLF

State Street Financial Select Sector SPDR ETF

44
$54.73+0.50 (+0.92%)
Financial Services
2 politicians both hold this
2 politicians
View Stock

IHI

iShares U.S. Medical Devices ETF

44
$51.74+0.64 (+1.25%)
Financial Services
2 politicians both hold this
2 politicians
View Stock

IDV

iShares International Select Dividend ETF

44
$41.670.00 (0.00%)
Financial Services
2 politicians both hold this
2 politicians
View Stock

Frequently Asked Questions about AMEFX

Which members of Congress have traded AMEFX?
3 members of Congress have disclosed 14 trades in American Funds Income Fd of Amer F-2 (AMEFX) under the STOCK Act. The most active traders are Sheldon Whitehouse, Raul Ruiz, and John R. Curtis.
When was AMEFX most recently disclosed by Congress?
The most recent AMEFX disclosure was filed by Sheldon Whitehouse on 30 December 2025.
What is the total disclosed congressional trading volume for AMEFX?
Members of Congress have disclosed approximately $48.5K in AMEFX purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in AMEFX?
This AMEFX page updates as soon as new STOCK Act disclosures are filed for American Funds Income Fd of Amer F-2. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.